Requests similar to 'Vanlafaxine - Bioavailability studies'
Arrow Venlafaxine needs to come back under NZ funding.
Response by Pharmaceutical Management Agency to VICKI CAREY on .
Partially successful.
Kia ora Vicki
Thank you for your enquiry. You have asked why the Arrow-Venlafaxine XR
and Efexor XR brands were removed when it was doing good f...
Cost of Effexor v's Enlafax
Response by Pharmaceutical Management Agency to Sarah Bellamy on .
Awaiting classification.
Hi Sarah
Thank you for your email regarding the wholesale cost to PHARMAC or NZ per year of Effexor XR and number of people funded, versus the wholesa...
Dear Trudi
Thank you for your query regarding the initial listing date for
Arrow-Venlafaxine XR tablets in the Pharmaceutical Schedule.
Ar...
Dispensed drugs, media and events information request
Response by Pharmaceutical Management Agency to Joe Heihei on .
Awaiting classification.
Dear Joe
Please see attached the response to your OIA request.
Kind regards
Dean Zeng
PHARMAC
25 May 2018
Dear Joe
REQUEST FO...
Reply to Maima Koro re Request H201803736.
Follow up sent to Ministry of Health by Trudi Webber on .
Dear Mr James,
Thank you for your reply to my request for information under the OIA. In response to your reply I have have a few questions that I...
Ministry of Health,
Medsafe
REF - H201803736
Thank you for your reply to my request for information under the OIA, made on the 8th May 2018. In...
Molnupiravir for Horses, Zebras & Donkeys - offspring born with no teeth & skull missing
Request sent to Pharmaceutical Management Agency by Micky Turner on .
Successful.
Pharmac just pre-ordered 60,000 treatment doses of Molnupiravir.
In regards to Molnupiravir - can you please provide the following information:...
35 - Ownership, governance, and operational rollout of the ADHD Clinical Principles Framework (February 2026)
Response by Ministry of Health to Elspeth Baker-Vevers on .
Partially successful.
Kia ora Elspeth
Please find attached part 3 of 5 of the response to your request for
official information.
Ngā mihi,
OIA Ser...
Copies of correspondence bteween MedSafe and Johnson & Johnson regarding Ortho EVRA
Response by Ministry of Health to Andrew Jull on .
Successful.
Kia ora,
Please find attached the response for your request for official
information.
Please note that owing to the size of the appendix, the PDF bi...
Removal of Approved Drugs / Medicine
Response by Ministry of Health to Chris McCashin on .
Awaiting classification.
Kia ora Chris,
Please find attached the response for your request for official
information.
Ngā mihi
OIA Services Team
Manatū Hauora | Mini...
Equity of access for low side-effect formulations for therapeutic treatment of anxiety, depression & ADHD
Response by Ministry of Health to J Bruning on .
Successful.
Kia ora J,
Please find attached the response to your request for official
information.
Ngā mihi
OIA Services Team
Manatū Hauora | Ministr...
Rolling reviews of safety & efficacy of (non-mRNA gene therapy) COVID-19 treatments
Request sent to Pharmaceutical Management Agency by J Bruning on .
Successful.
Please provide me with the following information that is held by Pharmac, that Pharmacology and Therapeutics Advisory Committee (PTAC) or the COVID-...
Stimulant medicine ADHD lisdexamfetamine - clear health benefit - efficacy and safety data
Response by Pharmaceutical Management Agency to J Bruning on .
Partially successful.
Kia ora J
Please find attached a response to your request for official information.
Ngâ mihi,
Government Services | Pharmac
________________________...
7 - ADHD Medicines, Funding, Access, and Equity
Response by Pharmaceutical Management Agency to Elspeth Baker-Vevers on .
Partially successful.
Kia ora Elspeth,
Please find attached our response letter and the relevant documents
released to you under the Official Information Act.
...
dexrazoxane NPPA Approval
Response by Pharmaceutical Management Agency to Ian Kennedy on .
Awaiting classification.
Dear Ian
This email is to acknowledge that your request for information under the
Official Information Act (1982) has been received and is curre...
All emails from the Chief Executive, Director of Operations and communications staff in 2022 mentioning continuous glucose monitors
Response by Pharmaceutical Management Agency to Stefan Clausing on .
Awaiting classification.
Kia ora Stefan,
Please find a response to your request attached to this email.
Kind regards,
Gendi McFadyen| Government Services Advisor
Te Pātaka W...
Supporting/supplementary documentation to the 1 & 2 November 2018 PTAC minutes on funding of Whole Thyroid Extract and Liothyronine
Response by Pharmaceutical Management Agency to Belinda Hodson on .
Awaiting classification.
Good morning Belinda
Please find attached PHARMAC's response to your recent request for information about the funding of Whole Thyroid Extract and Lio...
Meeting notes and outcomes
Response by Pharmaceutical Management Agency to A L.C on .
Awaiting classification.
Kia ora A L.C,
Please find attached a response to your Official Information Act request,
which was received on 26 September 2024.
Please c...
Pharmac Budget Bids
Response by Pharmaceutical Management Agency to Jennifer Jiayi on .
Awaiting classification.
Kia ora Jennifer
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac...
Request for list of HRT pharmaceuticals available in NZ and their funding status
Response by Pharmaceutical Management Agency to Amanda Ashley on .
Partially successful.
Dear Amanda
Thank you for your query regarding the availability and funding for
estradiol, testosterone and anti-androgen pharmaceuticals in New...
Kia ora El Zorro,
Please find attached a letter regarding your request for information.
Ngā mihi
OIA Services
Government Services...
Decision to delay Pump and CGM Funding for T1 Diabetics
Response by David Seymour to Fiona Smith on .
Awaiting classification.
Dear Fiona
Please find attached response to your OIA request of 29 May.
Kind regards, Annette
Annette Gratkowski | Private Secretary...
Pesticide safety in NZ especially full formulations and adjuvants mixed on-farm.
Request sent to Environmental Protection Authority by John Small on .
Partially successful.
Bearing in mind the distinction between safety testing of active ingredients, safety testing of formulation components separately, and safety testin...
Citation list for PHARMAC funded thyroid medications and patient survey data
Response by Pharmaceutical Management Agency to Belinda Hodson on .
Partially successful.
Dear Belinda
Please find attached further correspondence in relation to your request for information about thyroid medications (OIA reference 2019-20-...
Kia ora,
Please find attached a response to your Official Information Act request of 5 May 2024.
Thank you
Government Services - Pharmac
31 May 2024...